Lauri Ann Maitland, DO, MPH


Associate Professor of Family MedicineLauri Ann Maitland, DO, MPH

lamaitland@liberty.edu
(434) 582-2164

Education

  • DO, University of New England College of Osteopathic Medicine
  • MPH, Boston University School of Public Health
  • BA, Eastern Nazarene College

Biography

Dr. Maitland enjoys caring for large families and individuals of all ages. Prior to attending medical school, she was a senior research associate at Beth Israel Hospital/Harvard Medical School in Boston, MA, where she authored over a dozen journal articles on the topic of osteoporosis.

Her interests include pediatrics, women’s health, and preventative healthcare. She also has a passion for medical outreach and has participated in several international medical mission trips.

Courses Taught

  • Clerkship Director - Family Medicine Clerkship
  • Clerkship Director - Underserved Care Clerkship

Professional Memberships

  • American Academy of Family Physicians
  • Society of Teachers of Family Medicine
  • American Osteopathic Association
  • Virginia Osteopathic Association
  • Lynchburg Academy of Medicine
  • Christian Medical and Dental Association
  • Medical Society of Virginia

Publications

  • Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland L, Karpf DB. J Bone Miner Res. 1998 Sep; 13(9): 1431-8
  • Classification of Osteoporosis in the elderly is dependent on site-specific analysis. Greenspan SL, Maitland L, Myers E. Calcif Tissue Int. 1996 Jun; 58(6): 409-14
  • Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying Alendronate therapy. Greenspan SL, Holland S, Maitland L, Poku M, Freeman A, Yuan W, Kher U, Gertz B. Proc Assoc Am Physicians. 1996 May; 108(3): 230-8
  • Femoral bone loss progresses with age: a longitudinal study in women over age 65. Greenspan SL, Maitland LA, Meyers ER, Krasnow MB, Kido TH. J Bone Miner Res. 1994 Dec; 9(12): 1959-65
  • Trochanteric bone mineral density is associated with type of hip fracture in the elderly. Greenspan SL, Meyers ER, Maitland LA, Kido TH, Krasnow MB, Hayes WC. J Bone Miner Res. 1994 Dec; 9(12): 1889-94
  • Subregion analysis of the rat femur: a sensitive indicator of changes in bone density. Following treatment with thyroid hormone or bisphosphonates. Rosen HN, Middlebrooks VL, Sullivan EK, Rosenblatt M, Maitland LA, Moses AC. Greenspan SL. Calcif Tissue Int. 1994 Sep; 55(3): 173-5
  • Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. Greenspan SL, Meyers ER, Maitland LA, Resnick NM, Hayes WC. JAMA. 1994 Jan 12; 271(2): 128-33
  • Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats. Rosen HN, Sullivan EK, Middlebrooks VL, Zeind AJ, Gundberg C, Dresner-Pollack R, Maitland LA, Hock JM, Moses AC, Greenspan SL. J Bone Miner Res. 1993 Oct; 8(10): 1255-61
  • The Pituitary-adrenal glucocorticoid response is altered by gender and disease. Greenspan SL, Rowe JW, Maitland LA, McAloon-Dyke M, Elahi D. J Gerontol. 1993 May; 48(3): M72-7
  • Read my hips: measuring trochanteric soft tissue thickness. Maitland LA, Meyers ER, Hipp JA, Hayes WC, Greenspan SL. Calcif Tissue Int. 1993 Feb; 52(2): 85-9

Research Interests

  • Practice Quality Improvement
  • Medical Student's Interest/Attitudes toward Family Medicine
  • Social Determinants of Health